Portal de investigação
Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma.
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
The role of 5-hydroxymethylcytosine as a potential epigenetic biomarker in a large series of thyroid neoplasm.
Investigador Principal: Valdemar de Jesus Conde Máximo
Estudo Clínico Académico (Thyroid neoplasm) . 2023
Mitochondrial complex II genetic characterization and enzymatic expression profile in tumours of the adrenal cortex and medulla
Investigador Principal: Valdemar de Jesus Conde Máximo
Estudo Clínico Académico (Mitochondrial) . 2020
Selenium Clinical Supplementation In Autoimmune Thyroid Disease: A Portuguese Survey
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Squamous cell carcinogenesis of the skin: Molecular characterization of prognostic therapeutic biomakers
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Clinicopathological features and molecular biomarkers? role predicting papillary thyroid cancer patients? outcome: How to personalize and guide surgical treatment
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Role of the MITOchondrial fission protein DRP1 as a prognosis and predictive biomarker in the treatment of differentiated thyroid cancer (ROMITO-DRP1)
Investigador Principal: Valdemar de Jesus Conde Máximo
Estudo Clínico Académico . 2022
Fatores do microambiente tumoral no cancro do ovário.
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
New Biomarkers development, validation and application in Bladder Cancer.
Investigador Principal: Valdemar de Jesus Conde Máximo
Estudo Clínico Académico . 2021
Citar a publicação
Teixeira E,Fernandes C,Bungardean M,Paula AD,Lima RT,Batista R,Vinagre J,Sobrinho M,Maximo V,Soares P. Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma. Int. J. Mol. Sci. 2024. 25. (3):p. 1522-1522. IF:5,600. (1).
